Abstract
The development of morphine tolerance and naloxone-precipitated withdrawal was studied in intact cats and correlated with neocortical acetylcholine (ACh) release in midpontine pretrigeminal transected preparations. Cats were given morphine sulfate s.c. every 8 hours for 15 days. The dosage (calculated as base) was increased gradually from 9 to 30 mg/kg/day. On gross behavioral observation surviving cats showed obvious tolerance to morphine toward the end of the treatment period. Naloxone, 1.0 mg/kg i.v., induced a withdrawal syndrome characterized by predominant central nervous system depression, vomiting and stupor in five intact cats. The remaining animals were subjected to a midpontine pretrigeminal brainstem transection under halothane-air anesthesia. Subsequently, the neocortical release of ACh after i.v. morphine and/or naloxone was determined. Morphine-tolerant animals had a shift to the right in their dose-effect curves on arterial blood pressure and on inhibition of neocortical ACh release. Similarly electroencephalogram activation produced by acute morphine was less prolonged in the 15-day morphine-treated animals. Naloxone, 1.0 mg/kg i.v., produced an initial hypertension and electroencephalogram slow waves in the morphine-dependent cats. An initial inhibition of ACh release and a subsequent return to control ACh release levels with a possible enhanced release was observed. The data indicate a far more complex diphasic effect on neocortical ACh release during naloxone-precipitated withdrawal than was initially predicted.
Footnotes
- Received December 12, 1973.
- Accepted May 30, 1974.
- © 1974 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|